PH29985A - Substituted quinolines and medicinal use thereof - Google Patents

Substituted quinolines and medicinal use thereof

Info

Publication number
PH29985A
PH29985A PH37861A PH37861A PH29985A PH 29985 A PH29985 A PH 29985A PH 37861 A PH37861 A PH 37861A PH 37861 A PH37861 A PH 37861A PH 29985 A PH29985 A PH 29985A
Authority
PH
Philippines
Prior art keywords
stands
pct
carboxy
bond
stand
Prior art date
Application number
PH37861A
Other languages
English (en)
Inventor
Ian Ahnfelt-Ronne
Erik Torngaard Hansen
Dorte Kirstein
Ole Bent Tvaermose Nielsen
Schneur Rachlin
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of PH29985A publication Critical patent/PH29985A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Water Treatment By Sorption (AREA)
  • Optical Transform (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Quinoline Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Optical Head (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH37861A 1987-12-01 1988-11-25 Substituted quinolines and medicinal use thereof PH29985A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878728051A GB8728051D0 (en) 1987-12-01 1987-12-01 Chemical compounds

Publications (1)

Publication Number Publication Date
PH29985A true PH29985A (en) 1996-10-29

Family

ID=10627789

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37861A PH29985A (en) 1987-12-01 1988-11-25 Substituted quinolines and medicinal use thereof

Country Status (16)

Country Link
US (1) US5110819A (ko)
EP (1) EP0420844B1 (ko)
JP (1) JPH03501477A (ko)
KR (1) KR900700454A (ko)
AT (1) ATE110364T1 (ko)
CA (1) CA1336602C (ko)
DE (1) DE3851232T2 (ko)
ES (1) ES2011919A6 (ko)
GB (1) GB8728051D0 (ko)
GR (1) GR1000422B (ko)
IE (1) IE64473B1 (ko)
NZ (1) NZ227003A (ko)
PH (1) PH29985A (ko)
PT (1) PT89118B (ko)
WO (1) WO1989005294A1 (ko)
ZA (1) ZA888763B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
GB8919504D0 (en) * 1989-08-29 1989-10-11 Leo Pharm Prod Ltd Chemical compounds
US5021576A (en) * 1989-10-27 1991-06-04 American Home Products Corporation 2-Anilino phenylacetic acid derivatives
US5281593A (en) * 1990-07-31 1994-01-25 Lilly Industries Limited Certain indole derivatives useful as leukotriene antagonists
AU654140B2 (en) * 1990-07-31 1994-10-27 Lilly Industries Limited N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them
WO1994014797A1 (en) * 1992-12-23 1994-07-07 Smithkline Beecham Corporation Quinoline compounds and the treatment of leucotriene related diseases therewith
US5486612A (en) * 1993-12-14 1996-01-23 Eli Lilly And Company N-benzyl dihydroindole LTD4 antagonists
GB9414590D0 (en) * 1994-07-20 1994-09-07 Leo Pharm Prod Ltd Chemical compounds
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
US5602110A (en) * 1994-08-31 1997-02-11 Case Western Reserve University Method and composition for treating cystic fibrosis
EP0725063A1 (de) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Chinolin-Derivate
ES2117551B1 (es) * 1995-12-29 1999-04-01 Menarini Lab Quinolinas naftalenicas con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de las mismas.
US5756518A (en) * 1996-04-02 1998-05-26 Kowa Co., Ltd. Phenylene derivatives
CN1195739C (zh) * 1997-06-17 2005-04-06 科研制药株式会社 2－氨磺酰苯甲酸衍生物
US6376671B1 (en) 1997-06-17 2002-04-23 Kaken Pharmaceutical Co., Ltd. 2-sulfamoylbenzoic acid derivatives
JP2004137284A (ja) * 1997-06-17 2004-05-13 Kaken Pharmaceut Co Ltd ２−スルファモイル安息香酸誘導体
DE69805033T2 (de) * 1997-09-26 2002-11-14 Kowa Co., Ltd. Tetrazolderivate als LTD4 und H1 Antagonisten
IL145923A0 (en) * 1999-04-28 2002-07-25 Aventis Pharma Gmbh Tri-aryl acid derivatives as ppar receptor ligands
WO2001066098A2 (en) * 2000-03-09 2001-09-13 Aventis Pharma Deutschland Gmbh Therapeutic uses of ppar mediators
TW200418825A (en) 2002-12-16 2004-10-01 Hoffmann La Roche Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives
WO2005087710A1 (ja) * 2004-03-15 2005-09-22 Takeda Pharmaceutical Company Limited アミノフェニルプロパン酸誘導体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
IE58870B1 (en) * 1985-03-08 1993-11-17 Leo Pharm Prod Ltd Pyridine derivatives
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
DK282986A (da) * 1985-06-18 1987-02-24 Merck Frosst Canada Inc Substitueret quinolin og farmaceutisk praeparat indeholdende en saadan forbindelse
EP0219307A3 (en) * 1985-10-16 1987-10-14 Merck Frosst Canada Inc. 2-substituted quinolines
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
US4904786A (en) * 1986-01-27 1990-02-27 American Home Products Corporation Quinoline compounds as antiallergic and antiinflammatory agents
GB2185741B (en) * 1986-01-27 1989-10-25 American Home Prod Heterocyclic sulphonamides
IE59889B1 (en) * 1986-02-14 1994-04-20 Merck Frosst Canada Inc 2-substituted quinoline dioic acids
EP0271287A3 (en) * 1986-12-11 1990-06-13 Merck Frosst Canada Inc. Quinoline dioic acids and amides
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
ZA888763B (en) 1989-07-26
CA1336602C (en) 1995-08-08
DE3851232D1 (de) 1994-09-29
NZ227003A (en) 1991-11-26
PT89118B (pt) 1993-04-30
JPH03501477A (ja) 1991-04-04
KR900700454A (ko) 1990-08-13
PT89118A (pt) 1988-12-01
EP0420844B1 (en) 1994-08-24
IE64473B1 (en) 1995-08-09
ATE110364T1 (de) 1994-09-15
GB8728051D0 (en) 1988-01-06
WO1989005294A1 (en) 1989-06-15
DE3851232T2 (de) 1995-02-02
US5110819A (en) 1992-05-05
IE883419L (en) 1989-06-01
ES2011919A6 (es) 1990-02-16
EP0420844A1 (en) 1991-04-10
GR1000422B (el) 1992-06-30

Similar Documents

Publication Publication Date Title
PH29985A (en) Substituted quinolines and medicinal use thereof
ES2076935T3 (es) Compuesto de pirazolopiridina y procedimientos para su preparacion.
MA26697A1 (fr) Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant
EA199900242A1 (ru) Аралкил- и аралкилиден-гетероциклические лактамы и имиды
TR199900046T2 (xx) Se�ici siklooksijenaz-2 inhibit�rleri olarak ikameli piridinler.
SE8600913L (sv) Kemiska foreningar
DE3372707D1 (en) Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use
NO913923D0 (no) 17beta-substituerte-4-aza-5alfa-androstan-3-on-derivater ogfremgangsmaate ved fremstilling av disse
ATE152719T1 (de) Chinolylbenzofuran derivate als leukotrien- antagonisten
BG100692A (en) New heterocyclic compounds
HUP9902133A2 (hu) Mikroszomális trigliceridtranszfer-proteint gátló aromás inhibitorok
ATE212026T1 (de) Halo-substituierte protein kinase c inhibitoren
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
ES512574A0 (es) "procedimiento de preparacion de derivados carboxilato".
DE69315836D1 (de) Pyrazolpyridine für die behandlung der anämie
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
DK118390A (da) Substituerede quinoliner
ES8604958A1 (es) Un procedimiento de obtencion de imidazoquinolinas
DK449488D0 (da) Disubstituerede tetrazol-forbindelser med leukotrien-antagonistvirkning, fremgangsmaade til fremstil ling heraf og middel til brug ved fremgangsmaaden
RO82161A (ro) Procedeu pentru prepararea 2-(2-clor-4-ciclopropilfenilimino)-imidazolidinei